Olusola N. Majolagbe

Therapeutics Potential of Chlorella sorokiniana Bioactives against Sulphur Ester Dioxygenase (4CVY) in Multidrug-resistant Mycobacterium tuberculosis

Favour O. Olanrewaju, Olusola N. Majolagbe, Abdullahi A. Opatola, Oreoluwa H. Makinde, Esther B. Dahunsi, Damola G. Oyatokun, Ayanyemi B. Ayantunji, Alice A. Atilade, David B. Oloyede & Kafilat O. Arowasi · Journal of Advances in Microbiology · 2025

Introduction: Multidrug-resistant tuberculosis (MDR-TB) disease is caused by Mycobacterium tuberculosis that are resistant to at least one of the most effective TB medicines (Isoniazid and Rifampicin) used in treatment regimens. It remains one of the deadliest infectious diseases...

Open access Research Article 10.9734/jamb/2025/v25i121056

Metabolites of Endophytic Fungus Isolated from Stevia rebaudiana as Inhibitors of β-lactamase Multidrug Resistant Staphylococcus aureus

Grace O. Oluremi & Olusola N. Majolagbe · Microbiology Research Journal International · 2025

The rise of multidrug-resistant (MDR) bacteria, particularly Staphylococcus aureus, has created an urgent need for new antimicrobial compounds capable of overcoming β-lactamase-mediated resistance. This study investigated the metabolites of endophytic fungi isolated from Stevia r...

Open access Research Article 10.9734/mrji/2025/v35i121678